Effect of DCEP mobilizing regimen in in vivo purging of PBSC harvests in multiple myeloma

Leuk Lymphoma. 2004 Jul;45(7):1497-9. doi: 10.1080/10428190410001663644.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Purging / methods*
  • Cisplatin / administration & dosage
  • Cisplatin / pharmacology
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / pharmacology
  • Cytarabine / administration & dosage
  • Dexamethasone / administration & dosage
  • Dexamethasone / pharmacology
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Etoposide / pharmacology
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Hematopoietic Stem Cell Mobilization / methods*
  • Humans
  • Leukapheresis
  • Multiple Myeloma / blood
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / therapy*
  • Peripheral Blood Stem Cell Transplantation*
  • Transplantation, Autologous
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Vincristine
  • Etoposide
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin

Supplementary concepts

  • DCEP protocol
  • VAD protocol